Ibrutinib plus rituximab superior to standard treatment for some patients with chronic leukemia
04/12/2018
Chronic lymphocytic leukemia is one of the most common types of leukemia in adults typically occurring during or after middle age and rarely occurring in individuals under the age of 40.